|
Bay 11-7082 (BAY 11-7821)
Bay 11-7082 (BAY 11-7821) inhibits TNFα-induced IκBα phosphorylation with IC50 of 10 μM. The transcription factor NF-κB pla...
More>>
|
|
|
Pifithrin-α
Pifithrin-α is an inhibitor of p53, inhibiting p53-dependent transactivation of p53-responsive genes. It enhances cell survival after genotoxic ...
More>>
|
|
|
Apoptosis Activator 2
Apoptosis activator 2, a cell permeable indoledion compound, promotes the cytochrome c-dependent oligomerizatioin of Apaf-1 into the mature apoptosome...
More>>
|
|
|
Tenovin 1
Tenovin-1 is a p53 activator that protects against MDM-2 mediated degradation. Tenovin-1 has been shown to activate and elevate acetylated p53 levels,...
More>>
|
|
|
RITA (NSC 652287)
MDM-2 is a key negative regulator of p53 that binds to and targets p53 for proteasomal degradation. Overexpression of MDM-2 in some tumors leads to in...
More>>
|
|
|
NSC 207895 (XI 006)
NSC-207895 (XI-006) is a cell-permeable benzofuroxan compound that downregulates the p53 negative regulator MDMX protein level in MCF-7, LNCaP, and A5...
More>>
|
|
|
Lonafarnib (SCH 66336)
Lonafarnib (SCH66336) is a selectively farnesyl protein transferase (FPT) inhibitor of H-ras, K-ras-4B and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 n...
More>>
|
|
|
PAC-1
PAC-1 is a potent procaspase-3 activator with EC50 of 0.22 μM. Elevated caspase 3 level in cancer cell lines allows PAC1 to selectively induce apop...
More>>
|
|
|
Navitoclax (ABT 263)
Navitoclax (ABT-263) is a novel small molecule dual Bcl-2/Bcl-xL inhibitor designed to restore apoptosis, also known as programmed cell death, by bloc...
More>>
|
|
|
Obatoclax (GX15-070)
Obatoclax is an inhibitor of the Bcl-2 family of proteins with Ki of 0.22 μM. This inhibition induces apoptosis in cancer cells, preventing tumor g...
More>>
|
|
|
HA 14-1
HA 14-1, Cell-permeable inhibitor of Bcl-2 protein (IC50 9 μM), acts by binding t the surface pocket. Disrupts Bax/Bcl-2 interaction and induces ap...
More>>
|
|
|
ABT-737
ABT-737 is a cell-permeant pan-Bcl-2 inhibit that has a wide range of single-agent activity against acute lymphoblastic leukemia (ALL) cell lines and ...
More>>
|
|
|
TW-37
TW-37 is Bcl-2 inhibitor (Ki values are 0.29 μM and 1.11μM for Bcl-2 and Bcl-XL respectively). TW-37 inhibits the angiogenic potential of endoth...
More>>
|
|
|
Nutlin-3a (chiral)
Nutlin-3 is a MDM-2 antagonist with an IC50 of 90nM. It is the compound most commonly used in anti-cancer studies. Inhibiting the interaction between ...
More>>
|
|
|
Nutlin-3
Nutlin-3 is a MDM-2 antagonist with an IC50 of 90nM. It is the compound most commonly used in anti-cancer studies. Inhibiting the interaction between ...
More>>
|
|
|
Serdemetan (JNJ 26854165)
Serdemetan (JNJ-26854165) is a novel tryptamine compound which activated p53 and acts as a HDM2 ubiquitin ligase antagonist. It inhibits cell growth a...
More>>
|
|